Posters
« Back
MODEL-AD: Genetic models of late-onset Alzheimer’s disease
EP26690
Poster Title: MODEL-AD: Genetic models of late-onset Alzheimer’s disease
Submitted on 21 Nov 2017
Author(s): *A. OBLAK1,2, G. CARTER3, G. R. HOWELL3, B. LOGSDON4, L. MANGRAVITE4, K. NHO2, L. OMBERG4, K. D. ONOS3, V. PHILIP3, C. PREUSS3, S. J. SUKOFF RIZZO3, M. SASNER3, L. SHEN1,2, A. J. SAYKIN1,2, P. TERRITO1,2, A. UYAR3, H. WILLIAMS3, B. T. LAMB1,5
Affiliations: 1STARK Neurosci. Res. Inst., 2Radiology & Imaging Sciences, Indiana University School of Medicine, 3The Jackson Lab., Bar Harbor, ME; 4Sage Bionetworks, Seattle, WA; 5Medical & Molecular Genetics, Indiana University School of Medicine
This poster was presented at Society for Neuroscience 2017
Poster Views: 1,365
View poster »


Poster Information
Abstract: Alzheimer’s disease (AD) is the most common form of dementia, with no effective preventative strategies or treatments. One of the major obstacles of developing novel therapies for AD is the lack of predictive animal models to be used in preclinical trials of therapeutics. One reason for this may
be that existing models are based on familial mutations, while the vast majority of the clinical population has non-familial late-onsetAD (LOAD). The Model Organism Development and Evaluation for Late-onset AD (MODEL-AD) Center has been established as a consortium consisting of IndianaUniversity, TheJacksonLaboratory, and Sage Bionetworks. The goals of the Center are: to identify novel genetic variants, genes and biomarkers from AD patient data; to generate and validate new animal models based on these LOAD variants; and to utilize these novel models in a preclinical testing paradigm.
Summary: A brief overview into the Model Organism Development and Evaluation of Late Onset Alzheimer's Disease center and future goals.Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


2D FT0ICR MS/MS analysis of IgG1
Johanna Paris 1 , Tomos E. Morgan 1 , Yuko P. Y. Lam 1 Christopher A. Wootton 1 Mark André Delsuc 2 , Mark P. Barrow 1 , John O’Hara 3 , and Peter B. O’Connor 1

Development of an expert consensus based treatment recommendation for the PADOVAN METHOD® in neurorehabilitation
Eisenmeier, Dimitri1; Ostermann, Thomas1; Vogel, Hannah1; Fetz, Katharina1

Diagnostic outcomes of MRE as an investigation for NSS of small bowel disease: Can CTE be a cost-effective alternative in patients above 50 years old?
K ElGendy, E Musgrave, M Twemlow

The informativity of the radiological signs in childrens with birth injuries
Yurii Kolomiichenko, Ihor Voronzhev

Adequacy of image guided biopsies in view of new standards of practice issued by CIRSE
J Deakin, Z Habib, V Rachapalli